• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS CREATININE JAFFE GEN.2; CREATININE, ALKALINE PICRATE COLORIMETRY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS CREATININE JAFFE GEN.2; CREATININE, ALKALINE PICRATE COLORIMETRY Back to Search Results
Catalog Number 08057532190
Medical Device Problem Code Non Reproducible Results (4029)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 06/16/2025
Type of Reportable Event Malfunction
Event or Problem Description
There was an allegation of questionable creatinine jaffe gen.2 results from the cobas c 503 analytical unit.The initial result was 2.81 mg/dl, which did not align with the patient's clinical profile.The doctor contacted the laboratory and asked to repeat the test.On (b)(6) 2025, the same sample was repeated, and the result was 1.75 mg/dl.
 
Additional Manufacturer Narrative
The cobas c 503 analytical unit serial number was (b)(6).The investigation is ongoing.
 
Additional Manufacturer Narrative
Due to the limited information provided, the investigation was unable to determine a specific root cause.A general reagent problem could be excluded because the quality control results were acceptable.There was no product problem identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CREATININE JAFFE GEN.2
Common Device Name
CREATININE, ALKALINE PICRATE COLORIMETRY
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhofer strasse 116
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
natalie catton
9115 hague road
indianapolis, IN 46250
MDR Report Key22393784
Report Number1823260-2025-02041
Device Sequence Number21099829
Product Code CGX
UDI-Device Identifier07613336121177
UDI-Public07613336121177
Combination Product (Y/N)N
Initial Reporter CountrySP
PMA/510(K) Number
K951595
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Health Professional,User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 07/17/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue Number08057532190
Device Lot Number869384
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 06/17/2025
Supplement Date Received by Manufacturer07/16/2025
Initial Report FDA Received Date07/03/2025
Supplement Report FDA Received Date07/17/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
DUROFENTA; ENOXAPARIN; LACTULOSE; LEVOTHYROXINE; NORFLOXACIN; OLIC ACID; PARACETAMOL; SPIRAXIN; TRAMADOL; WEGOVY
Patient Age52 YR
Patient SexFemale
-
-